
Business Update24 Jun 2026, 04:11 pm
Karkinos Healthcare Completes 1 Lakh HPV DNA Tests
AI Summary
Reliance Industries' subsidiary, Karkinos Healthcare, has achieved a significant milestone by completing HPV DNA screening for over one lakh women across India. This accomplishment strengthens India's cervical cancer prevention efforts by expanding access to high-quality screening and follow-up care. Karkinos Healthcare's model utilizes a digitally enabled care continuum, integrating community outreach, HPV DNA testing, navigation, and treatment linkage to address challenges in screening access and patient follow-up. The initiative aims to reach underserved communities and contribute to India's goal of eliminating cervical cancer.
Key Highlights
- Karkinos Healthcare, a Reliance subsidiary, screened over 100,000 women.
- Milestone strengthens India's cervical cancer prevention efforts.
- Focus on digitally enabled care continuum and follow-up.
- Aims to expand access to screening in districts and small towns.
- Supports India's goal of cervical cancer elimination.
Price Impact
More from RELIANCE